GILD - GILEAD SCIENCES, INC.
117.41
1.370 1.167%
Share volume: 14,406,035
Last Updated: 03-07-2025
Research and Development in Biotechnology (except Nanobiotechnology):
-0.45%
PREVIOUS CLOSE
CHG
CHG%
$116.04
1.37
0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 08-04-2023 | 11-07-2023 | 02-23-2024 | 05-08-2024 | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | |
| Total revenue | 6.599 B | 7.050 B | 7.115 B | 6.686 B | 6.686 B | 6.954 B | 7.545 B | 7.569 B | |
| Cost of revenue | 1.442 B | 1.565 B | 2.090 B | 1.552 B | 1.552 B | 1.544 B | 1.574 B | 1.581 B | |
| Gross profit | 5.157 B | 5.485 B | 5.025 B | 5.134 B | 5.134 B | 5.410 B | 5.971 B | 5.988 B | |
| 6.36% | -8.39% | 2.17% | 0.00% | 5.38% | 10.37% | 0.28% | |||
| Operating expenses | 3.256 B | 2.772 B | 3.014 B | 7.026 B | 2.895 B | 2.766 B | 3.333 B | 3.536 B | |
| Selling general and admin | 1.849 B | 1.315 B | 1.607 B | 1.375 B | 1.375 B | 1.377 B | 1.433 B | 1.906 B | |
| Research and development | 1.407 B | 1.457 B | 1.407 B | 5.651 B | 1.520 B | 1.389 B | 1.900 B | 1.630 B | |
| Total expenses | 4.698 B | 4.337 B | 5.104 B | 9.456 B | 4.447 B | 2.766 B | 5.083 B | 3.536 B | |
| -7.68% | 17.69% | 85.27% | -52.97% | -37.80% | 83.77% | -30.43% | |||
| Operating income | 1.901 B | 2.713 B | 2.011 B | -4.322 B | 2.239 B | 2.644 B | 888.000 M | 2.452 B | |
| Ebit | 1.901 B | 2.713 B | 2.011 B | -4.231 B | 2.239 B | 2.289 B | 1.194 B | 2.416 B | |
| Pretax income | 1.587 B | 2.318 B | 1.654 B | -4.486 B | -4.485 B | 2.053 B | 956.000 M | 2.167 B | |
| 46.06% | -28.65% | -371.22% | -0.02% | -145.77% | -53.43% | 126.67% | |||
| Income tax | 549.000 M | 146.000 M | 236.000 M | -315.000 M | -315.000 M | 438.000 M | -297.000 M | 385.000 M | |
| Net income basic | 1.045 B | 2.180 B | 1.429 B | 0.000 | -4.170 B | 0.000 | 0.000 | 0.000 | |
| 108.61% | -34.45% | -100.00% | 100.00% | ||||||
| Net income | 1.045 B | 2.180 B | 1.429 B | -4.170 B | -4.170 B | 1.614 B | 1.253 B | 1.783 B | |
| 108.61% | -34.45% | -391.81% | 0.00% | 138.71% | -22.37% | 42.30% |